Blog | Veristat Insights

Delivering Smarter, Faster & Patient-Centric  Clinical Trials with Integrated Clinical Technologies

November 17, 2017

A Recap of the New York Medidata NEXT Event: Where Science Meets Technology Meets the Future

 

Kathleen Boruchowski, Associate Director of Data Management, attended the Medidata NEXTconference in New York City on November 8-10. The conference, which has many global locations throughout the year, offered Medidata’s customers a front row seat to learn how data, insights, and technology are transforming the clinical trials industry and ultimately accelerating the hope for patients desperately seeking new treatment options.

Read More

Clinical Development Is A Team Sport

November 8, 2017

Veristat Hosts Its 2017 Annual International Company Meeting

Last week, Veristat gathered nearly 200 team members from multiple countries for our annual International Company Meeting.    What better a place to host our team meeting than Gillette Stadium, home to the five-time Superbowl championship winning New England Patriots.  

Read More

Fight Or Flight:  Reflections on Veristat's Light The Night Experience

October 27, 2017

If you heard the phrase, “You have cancer,” what would be your response?

Read More

Competing Risk Analysis in Clinical Trials | A Practical Example

October 3, 2017

In pharmaceutical clinical trials, considering competing risk analyses is highly important. Competing risks are events that may occur and prevent the evaluation of a specific primary endpoint, in turn biasing risk estimations or drug efficacy. 

Read More

Veristat Launches New eTMF System

August 15, 2017

To Improve Real-Time Visibility of Clinical Trial Documentation and Inspection-Readiness

Veristat has completed the validation and configuration of Master Control’s eTMF system, which is now implemented and available for Veristat managed clinical trials. 

Read More

Celebrating The Success of Velcade | 14 Years Later

August 3, 2017

Last week, Veristat attended the Massachusetts Biotechnology Council (MassBio) forum titled “Evolution of an Academic Discovery: First Person Account of the Development of Velcade®”.   

Read More

Veristat Participates in Cycle for Survival 2017 and Raises over $25,000 to Fund Rare Cancer Research

February 23, 2017

On Saturday, February 4, Team Veristat joined the battle against rare cancers at the 2017 Cycle for Survival event! Team Veristat had 14 riders at the Boston, MA event, including 2 colleagues from our UK office.  Our team surpassed our goal of raising over $25,000 to fund rare cancer research!

Read More

Be a Trusted Friend

January 5, 2017

For anyone who follows this blog with even moderate consistency, it is probably clear that Veristat is a growing organization.  It is hopefully just as apparent that we are a group who tremendously values and fiercely protects our culture. 

Read More

How Do You Make Informed Decisions about Implementing Adaptive Designs?

December 15, 2016

Read more about this and the discussions that you missed at the MassBio Forum on Adaptive Designs in Clinical Research that took place last month.

Read More